Deng Guoren, Kakar Sanjay, Kim Young S
Department of Medicine, Veterans Affairs Medical Center, University of California at San Francisco, San Francisco, CA 94121, USA.
Oncol Lett. 2011 Jan;2(1):175-180. doi: 10.3892/ol.2010.222. Epub 2010 Nov 23.
MicroRNAs (miRs) are a class of small RNAs that regulate gene expression at the post-transcriptional and/or translational level by interacting with their target mRNAs. miRs are down-regulated or up-regulated in various cancer types, triggering abnormal cell differentiation, proliferation and apoptosis. miR-124a and miR-34b/c have been reported to be expressed at lower levels in colorectal cancer (CRC) due to methylation of these genes. The present study aimed to determine the methylation status of miR-124a and miR-34b/c in CRCs and polyps of various histological types, adjacent normal mucosa and ulcerative colitis. The colon cancer cell line study showed an association of the lower expression of miR-124a and miR-34b/c with the methylation of these genes and induction of the expression of these genes with the treatment by 5-aza-2'-deoxycytidine. Among nine different cancer types examined, CRC showed the highest frequency of methylation of miR-124a (cell lines 88% and tissues 99%) and miR-34b/c (cell lines 89% and tissues 93%). Mucinous and non-mucinous CRCs and all the histological types of colorectal polyps showed a high frequency of methylation of miR-124a and miR-34b/c. Notably, methylation of miR-124a (59%) and miR-34b/c (26%) was observed in the adjacent normal mucosa of CRC patients, but not in colonic mucosa from patients without cancer or with ulcerative colitis. The methylation of miR-124a in the adjacent normal mucosa was associated with the microsatellite instability of CRC, while the methylation of miR-34b/c was associated with an older age at diagnosis of CRC. The results showed that the methylation of miR-124a and miR-34b/c occured early in colorectal carcinogenesis and certain CRCs may arise from a field defect defined by the epigenetic inactivation of miRs.
微小RNA(miR)是一类小RNA,通过与靶mRNA相互作用在转录后和/或翻译水平调节基因表达。miR在各种癌症类型中表达下调或上调,引发异常的细胞分化、增殖和凋亡。据报道,由于这些基因的甲基化,miR-124a和miR-34b/c在结直肠癌(CRC)中表达较低。本研究旨在确定miR-124a和miR-34b/c在不同组织学类型的CRC、息肉、相邻正常黏膜和溃疡性结肠炎中的甲基化状态。结肠癌细胞系研究表明,miR-124a和miR-34b/c的低表达与这些基因的甲基化相关,而用5-氮杂-2'-脱氧胞苷处理可诱导这些基因的表达。在所检测的九种不同癌症类型中,CRC中miR-124a(细胞系88%,组织99%)和miR-34b/c(细胞系89%,组织93%)的甲基化频率最高。黏液性和非黏液性CRC以及所有组织学类型的大肠息肉均显示miR-124a和miR-34b/c的甲基化频率较高。值得注意的是,在CRC患者的相邻正常黏膜中观察到miR-124a(59%)和miR-34b/c(26%)的甲基化,但在无癌患者或溃疡性结肠炎患者的结肠黏膜中未观察到。CRC相邻正常黏膜中miR-124a的甲基化与CRC的微卫星不稳定性相关,而miR-34b/c的甲基化与CRC诊断时的年龄较大相关。结果表明,miR-124a和miR-34b/c的甲基化在结直肠癌发生早期就已出现,某些CRC可能源于由miR的表观遗传失活所定义的场缺陷。